SCHEMBL20206152

SCHEMBL20206152

CC(C)(C)OC(=O)Nc1ccc(C(=O)Nc2ccc(NC(=O)c3cccc(Br)n3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.59
GRM5 P41594 1/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP17A1 P05093 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20206127 0.96 NAMPT (0.57) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL20206151 0.95 GAA (0.51) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL20206125 0.91 NAMPT (0.52) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL20189983 0.88 STAT3 (0.52) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL24021427 0.88 GRM5 (0.49) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL20206126 0.87 KAT6A (0.52) NAMPTGRM5MEN1KMT2ACYP17A1
SCHEMBL23898933 0.86 GAA (0.61) NAMPTGAAKDM4EMEN1KMT2A
SCHEMBL20206136 0.85 NAMPT (0.45) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL24021470 0.83 NAMPT (0.41) NAMPTGRM5GAAKDM4EMEN1
SCHEMBL24021477 0.82 GRM5 (0.46) NAMPTGRM5KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544970-B1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA FARBER CANCER INST INC (US) 2021-11-17 EP disclosed
WO-2018098367-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 WO disclosed